Babyhaler--a new paediatric aerosol device

Area of Science:

• Pediatric Pulmonology
• Respiratory Drug Delivery
• Biomedical Engineering

Background:

• Nebulizers are traditional but have low compliance in infants due to long treatment times and cooperation issues.
• Metered-dose inhalers (MDIs) with valved holding chambers are emerging as alternatives for infant inhalation therapy.
• Infant breathing patterns (high frequency, low tidal volume) differ significantly from adults, impacting drug delivery device design.

Purpose of the Study:

• To evaluate the suitability of metered-dose inhaler (MDI) systems for drug delivery in infants.
• To identify optimal technical and physiological conditions for effective aerosol inhalation in infants with lung disease.
• To assess the design parameters of valved holding chambers for infant use.

Main Methods:

• Analysis of infant respiratory physiology and breathing patterns.
• Evaluation of aerosol particle size distribution requirements for lung deposition.
• Assessment of valved holding chamber characteristics, including volume and dimensions.
• Description of the Babyhaler device (230mm length, 350ml volume, low-resistance valves).

Main Results:

• Infant breathing patterns necessitate specific conditions for efficient drug delivery.
• Adequate aerosol particle size and appropriate spacer volume (5-10 breaths) are critical for efficacy.
• Spacer device dimensions must minimize particle impaction and deposition within the chamber.
• The Babyhaler design incorporates features to address infant respiratory needs.

Conclusions:

• Metered-dose inhaler (MDI) systems with valved holding chambers can overcome nebulizer compliance limitations in infants.
• Optimized spacer design and consideration of infant breathing patterns are essential for effective inhaled therapy.
• The Babyhaler represents a device designed to meet the specific requirements of aerosol drug delivery in infants.